Insider Trading & Ownership - Klassen Preston

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Klassen Preston
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-01-26
Sale
2023-01-27
4:42 pm
Metacrine Inc.MTCRKlassen Preston
President & CEO
380,605$0.4132$157,266541,905
(Direct)
View
2022-04-19
Sale
2022-04-20
4:25 pm
Metacrine Inc.MTCRKlassen Preston
President & CEO
44,748$0.50219$22,472922,510
(Direct)
View
2021-05-20
Purchase
2021-05-20
6:55 pm
Metacrine Inc.MTCRKlassen Preston
President & CEO
20,547$3.6352$74,69220,547
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-20
Option Award
2024-05-21
4:22 pm
N/A
2034-05-19
Regulus Therapeutics Inc.RGLSKlassen Preston
President & Head of R & D
528,000$0528,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
5:18 pm
N/A
2034-01-11
Regulus Therapeutics Inc.RGLSKlassen Preston
President & Head of R & D
120,000$0120,000
(Direct)
View
2023-08-10
Option Award
2023-08-14
4:24 pm
N/A
2033-08-09
Regulus Therapeutics Inc.RGLSKlassen Preston
President & Head of R & D
225,000$0225,000
(Direct)
View
2023-06-12
Option Award
2023-06-12
4:48 pm
N/A
2033-06-11
Regulus Therapeutics Inc.RGLSKlassen Preston
President & Head of R & D
350,000$0350,000
(Direct)
View
2023-03-23
Disposition
2023-03-24
12:35 pm
N/A
2032-02-26
Metacrine Inc.MTCRKlassen Preston
Director
842,211$01,384,116
(Direct)
View
2023-03-23
Option Award
2023-03-24
12:35 pm
N/A
N/A
Metacrine Inc.MTCRKlassen Preston
Director
842,211$0.471,384,116
(Direct)
View

Ownership
2023-03-21
7:35 pm
N/A
2033-03-15
Zura Bio LtdZURAKlassen Preston
President and COO
0$0476,756
(Direct)
View
2022-04-14
Option Award
2022-04-18
5:28 pm
N/A
N/A
Metacrine Inc.MTCRKlassen Preston
President & CEO
104,500$0967,258
(Direct)
View
2022-02-27
Option Award
2022-03-01
4:56 pm
N/A
2032-02-26
Metacrine Inc.MTCRKlassen Preston
President & CEO
842,211$01,704,969
(Direct)
View
2021-02-10
Option Award
2021-02-12
5:03 pm
N/A
2031-02-09
Metacrine Inc.MTCRKlassen Preston
President & CEO
247,500$0247,500
(Direct)
View

Ownership
2020-09-15
4:43 pm
N/A
2030-06-08
Metacrine Inc.MTCRKlassen Preston
President & CEO
0$0970,822
(Direct)
View
2020-03-01
Option Award
2020-03-03
6:15 pm
N/A
2027-03-01
ARENA PHARMACEUTICALS INCARNAKlassen Preston
EVP and CMO
70,000$070,000
(Direct)
View